MONOAMINE-DEPLETING DRUGS

被引:33
作者
CARLSSON, A [1 ]
机构
[1] UNIV GOTHENBURG,DEPT PHARMACOL,S-40033 GOTHENBURG 33,SWEDEN
来源
PHARMACOLOGY & THERAPEUTICS PART B-GENERAL & SYSTEMATIC PHARMACOLOGY | 1975年 / 1卷 / 03期
关键词
D O I
10.1016/0306-039X(75)90045-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:393 / 400
页数:8
相关论文
共 58 条
  • [21] Carlsson A, 1965, HDB EXP PHARMAKOL, V19, P529
  • [22] CENTRAL EFFECTS OF AN INHIBITOR OF TYROSINE HYDROXYLATION
    CORRODI, H
    HANSON, LCF
    [J]. PSYCHOPHARMACOLOGIA, 1966, 10 (02): : 116 - 116
  • [23] DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1
  • [24] DAHLSTROM A, 1970, NEW ASPECTS STORAGE, P20
  • [25] EULER USV, 1968, BIOCHEMICAL ASPECTS
  • [26] FREDHOLM BERTIL, 1966, LIFE SCI, V5, P2023, DOI 10.1016/0024-3205(66)90275-X
  • [27] HAGGENDAL J, 1963, ACTA PHYSIOL SCAND, V57, P431
  • [28] EFFECT OF NERVE STIMULATION ON CATECHOLAMINES TAKEN UP IN ADRENERGIC NERVES AFTER RESERPINE PRETREATMENT
    HAGGENDAL, J
    MALMFORS, T
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1969, 75 (1-2): : 33 - +
  • [29] DISCLOSURE OF LABILE MONOAMINE FRACTIONS IN BRAIN + THEIR CORRELATION TO BEHAVIOUR
    HAGGENDAL, J
    LINDQVIST, M
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1964, 60 (04): : 351 - &
  • [30] HAGGENDAL J, 1971, MEM SOC ENDOCR, V19, P651